Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 28, 2022
Patent Application Number
16381158
Date Filed
April 11, 2019
Patent Primary Examiner
Biomarkers are provided that are predictive of a subject's responsiveness to a therapy comprising a JAK inhibitor. The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for a subject having, suspected of having, or at risk of developing Graft-Versus-Host Disease.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
